Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schlesinger

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Plos One|January 19, 2018
The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formationJan Moritz Ponert, Svenja Schwarz, Reza Haschemi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 29, 2020
β<sub>1</sub>-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transportersFabian Baltes, Vladlena Pfeifer, Katja Silbermann, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 8, 2015
Inhibition of chemokine receptor CCR2 reduces sarcoma cell transendothelial migration and metastasis to the lungsMartin Schlesinger, Reiner Zeisig, Katrin Ortmann, et al.
International Journal of Molecular Sciences|December 8, 2020
Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization StrategiesKathleen Wantoch von Rekowski, Philipp König, Svenja Henze, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2015
Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasisMarko Roblek, Manuela Calin, Martin Schlesinger, et al.
Biomolecules|November 30, 2019
The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer CellsKathleen Wantoch von Rekowski, Philipp König, Svenja Henze, et al.
Lipids in Health and Disease|July 12, 2015
Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastasesAnna Raynor, Peter Jantscheff, Thomas Ross, et al.
Journal of Nanobiotechnology|July 13, 2016
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapiesSavita Bisht, Martin Schlesinger, Alexander Rupp, et al.
Molecular Cancer Therapeutics|January 12, 2011
Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivoPeter Jantscheff, Martin Schlesinger, Juliane Fritzsche, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Plos One|January 19, 2018
The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formationJan Moritz Ponert, Svenja Schwarz, Reza Haschemi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 29, 2020
β<sub>1</sub>-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transportersFabian Baltes, Vladlena Pfeifer, Katja Silbermann, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 8, 2015
Inhibition of chemokine receptor CCR2 reduces sarcoma cell transendothelial migration and metastasis to the lungsMartin Schlesinger, Reiner Zeisig, Katrin Ortmann, et al.
International Journal of Molecular Sciences|December 8, 2020
Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization StrategiesKathleen Wantoch von Rekowski, Philipp König, Svenja Henze, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2015
Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasisMarko Roblek, Manuela Calin, Martin Schlesinger, et al.
Biomolecules|November 30, 2019
The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer CellsKathleen Wantoch von Rekowski, Philipp König, Svenja Henze, et al.
Lipids in Health and Disease|July 12, 2015
Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastasesAnna Raynor, Peter Jantscheff, Thomas Ross, et al.
Journal of Nanobiotechnology|July 13, 2016
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapiesSavita Bisht, Martin Schlesinger, Alexander Rupp, et al.
Molecular Cancer Therapeutics|January 12, 2011
Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivoPeter Jantscheff, Martin Schlesinger, Juliane Fritzsche, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.
Pageof 5